Your browser doesn't support javascript.
loading
Corrigendum to "Future directions in managing aniridia-associated keratopathy" [Surv Ophthalmol 68 (2023) 940-956].
van Velthoven, Arianne J H; Utheim, Tor P; Notara, Maria; Bremond-Gignac, Dominique; Figueiredo, Francisco C; Skottman, Heli; Aberdam, Daniel; Daniels, Julie T; Ferrari, Giulio; Grupcheva, Christina; Koppen, Carina; Parekh, Mohit; Ritter, Thomas; Romano, Vito; Ferrari, Stefano; Cursiefen, Claus; Lagali, Neil; LaPointe, Vanessa L S; Dickman, Mor M.
Afiliación
  • van Velthoven AJH; MERLN Institute for Technology-Inspired Regenerative Medicine, Maastricht University, Maastricht, the Netherlands; University Eye Clinic Maastricht, Maastricht University Medical Center+, Maastricht, the Netherlands.
  • Utheim TP; Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway; Department of Ophthalmology, Oslo University Hospital, Oslo, Norway.
  • Notara M; Department of Ophthalmology, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
  • Bremond-Gignac D; Ophthalmology Department, University Hospital Necker-Enfants Malades, APHP, Paris Cité University, Paris, France; Centre de Recherche des Cordeliers, Sorbonne Paris Cité University, Paris, France.
  • Figueiredo FC; Department of Ophthalmology, Royal Victoria Infirmary, Newcastle upon Tyne, UK; Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.
  • Skottman H; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
  • Aberdam D; Centre de Recherche des Cordeliers, Sorbonne Paris Cité University, Paris, France.
  • Daniels JT; UCL Institute of Ophthalmology, London, UK.
  • Ferrari G; Cornea and Ocular Surface Unit, Eye Repair Lab, San Raffaele Hospital, Milan, Italy.
  • Grupcheva C; Department of Ophthalmology and Visual Sciences, Medical University of Varna, Varna, Bulgaria.
  • Koppen C; Department of Ophthalmology, Antwerp University Hospital, Edegem, Belgium.
  • Parekh M; Schepens Eye Research Institute, Harvard Medical School, Boston, MA, USA.
  • Ritter T; Regenerative Medicine Institute, University of Galway, Galway, Ireland.
  • Romano V; Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, Ophthalmology Clinic, University of Brescia, Brescia, Italy.
  • Ferrari S; Fondazione Banca degli Occhi del Veneto, Venice, Italy. Electronic address: stefano.ferrari@fbov.it.
  • Cursiefen C; Department of Ophthalmology, Faculty of Medicine and University Hospital Cologne, Cologne, Germany; Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany.
  • Lagali N; Division of Ophthalmology, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
  • LaPointe VLS; MERLN Institute for Technology-Inspired Regenerative Medicine, Maastricht University, Maastricht, the Netherlands.
  • Dickman MM; MERLN Institute for Technology-Inspired Regenerative Medicine, Maastricht University, Maastricht, the Netherlands; University Eye Clinic Maastricht, Maastricht University Medical Center+, Maastricht, the Netherlands.
Surv Ophthalmol ; 69(2): 300-301, 2024.
Article en En | MEDLINE | ID: mdl-38326136

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Surv Ophthalmol Año: 2024 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Surv Ophthalmol Año: 2024 Tipo del documento: Article País de afiliación: Países Bajos